Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized
by the accumulation of acquired somatic genetic alterations in hematopoietic progenitor …

Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived
from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of …

Genetics play an increasingly important role in the risk stratification and management of
acute myeloid leukemia (AML) patients. Traditionally, AML classification and risk …

Acute myeloid leukemia (AML) is a group of hematological diseases, phenotypic and
genetically heterogeneous, characterized by abnormal accumulation of blast cells in the …

The list of acquired mutations with clinical value in AML is growing. Clinical implementation
of this multitude of markers will require integrated approaches and selection of markers to …

Acute myeloid leukemia (AML) is a neoplasm of immature myeloid cells and is associated
with a wide variety of clinical presentations, morphological features, immunophenotypes …

Acute myelocytic leukemia (AML) is a malignant neoplasm of hematopoietic cells
characterized by an abnormal proliferation of myeloid precursor cells, decreased rate of self …

The most common acute leukemia in adults is acute myeloid leukemia (AML). The
pathophysiology of the disease associates with cytogenetic abnormalities, gene mutations …

Acute myeloid leukemia (AML) is a hematopoietic disorder in which there are too many
immature blood-forming cells accumulating in the bone marrow and interfering with the …

Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has
led to remarkable advances in our understanding of the disease. Mutations now allow us to …